ALAUNOS THERAPEUTICS INC
TCRT · NASDAQ
Updated at 2026-10-13 15:23:11
- Today's High
- $3.12
- Today’s Low
- $1.51
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $0.77
- Previous Close
- $1.05
- Volume
- 3.42M
- Market Cap
- $3.07M
- P/E Ratio
- --
- EPS
- $-1.82
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 501 E. LAS OLAS BLVD., FORT LAUDERDALE, FL, UNITED STATES, 33301
- Country
- US
- Listing Date
- 2004-08-20
- Fiscal Year End
- December
- Shares Outstanding
- 2.44M
- CIK
- 0001107421
- Website
- alaunos.com
Alaunos Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on discovering, acquiring, developing and commercializing a portfolio of immuno-oncology therapies to treat cancer patients. The company is headquartered in Houston, Texas.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$3K
2025-09-30
$0
Operating Expenses
2026-06-30
$943K
2026-03-31
$1M
2025-12-31
$549K
2025-09-30
$718K
Net Income
2026-06-30
-$952K
2026-03-31
-$1M
2025-12-31
-$893K
2025-09-30
-$1.15M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
-29.76K%
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.41
2026-03-31
--
2025-12-31
--
2025-09-30
$-0.55
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$943K
2026-03-31
-$998K
2025-12-31
-$886K
2025-09-30
-$1.15M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $3K | $0 |
| Operating Expenses | $943K | $1M | $549K | $718K |
| Net Income | -$952K | -$1M | -$893K | -$1.15M |
| Net Profit Margin | -- | -- | -29.76K% | -- |
| Earnings Per Share | $-0.41 | -- | -- | $-0.55 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$943K | -$998K | -$886K | -$1.15M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.